Maravai LifeSciences Affirms FY2026 Sales Guidance of $205.000M-$215.000M vs $210.433M Est

Benzinga Newsdesk www.benzinga.com Negative 59.1%

Neg 59.1% Neu 0% Pos 0%

Maravai LifeSciences (NASDAQ:MRVI) affirms FY2026 sales outlook from $205.000 million-$215.000 million to $205.000 million-$215.000 million vs $210.433 million estimate.